Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
Razieh Parizad, Researcher at Tabriz University of Medical Sciences, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Exploration of Neuroprotective Therapy, adding:
“Excited to share that our systematic review, ‘Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety’, has been published in Exploration of Neuroprotective Therapy.
This systematic review evaluates the efficacy and safety of FXI inhibitors compared to DOACs for stroke prevention in atrial fibrillation.
Key findings include a significant reduction in major bleeding with FXI inhibitors, although DOACs were more effective in preventing stroke or systemic embolism.
I am grateful to express my sincere gratitude to Dr. Bata for his invaluable mentorship, guidance, and support throughout this work.
I am also grateful to my co-authors for their collaboration and contributions.”
Title: Factor XI inhibitors versus direct oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of efficacy and safety
Authors: Razieh Parizad, Juniali Hatwal, Haleh Bodagh, Akash Batta, Bishav Mohan
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS
-
Jun 6, 2026, 06:03Mirriam Akiru: What Does Melena Indicate?
-
Jun 6, 2026, 05:59Eugene Fan: FIBOM-AI – Predicting Marrow Fibrosis From Routine Blood Counts